Literature DB >> 2543246

The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma.

J P Arm1, C E Horton, B W Spur, J M Mencia-Huerta, T H Lee.   

Abstract

The effects of dietary supplementation with fish oil lipids on the airways responses to allergen and neutrophil biochemistry and function have been studied in 17 atopic asthmatic subjects. Nine subjects received 18 capsules of Max-EPA (3.2 g eicosapentaenoic acid and 2.2 g docosahexaenoic acid) a day and eight subjects received identical capsules containing olive oil, for 10 wk in a double-blind fashion. There were no differences between prediet values and those observed after dietary supplementation with Max-EPA or placebo in the dose of allergen causing an acute asthmatic response as assessed by a 35% fall in specific airways conductance (PD35), the extinction dose of allergen on skin prick testing, the histamine PD35, or the total serum IgE concentrations. Twelve of the 17 subjects developed late asthmatic responses after allergen challenge prediet. Six of these subjects received Max-EPA, and six received placebo capsules. As compared to prediet values, the magnitude of the allergen-induced late asthmatic response was significantly attenuated from 2 to 7 h after allergen challenge following dietary supplementation with Max-EPA (p less than 0.005) but not with placebo. The attenuation of the late response was not accompanied by any significant change in the clinical severity of disease as assessed by diurnal peak expiratory flow rates, symptom scores, or bronchodilator drug usage.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543246     DOI: 10.1164/ajrccm/139.6.1395

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  22 in total

1.  The early life origins of asthma and related allergic disorders.

Authors:  J O Warner
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

Review 2.  Dietary components with demonstrated effectiveness in decreasing the severity of exercise-induced asthma.

Authors:  Timothy Mickleborough; Robert Gotshall
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Diet and asthma in Dutch school children (ISAAC-2).

Authors:  C Tabak; A H Wijga; G de Meer; N A H Janssen; B Brunekreef; H A Smit
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

4.  Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.

Authors:  Ruan Cox; Oluwakemi Phillips; Jutaro Fukumoto; Itsuko Fukumoto; Prasanna Tamarapu Parthasarathy; Stephen Arias; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

Review 5.  Controversial forms of treatment for asthma.

Authors:  P Chanez; J Bousquet; P Godard; F B Michel
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

6.  Fatty acid composition of phospholipids of plasma and of mononuclear blood cells in children with allergic asthma and the influence of glucocorticoids.

Authors:  M Griese; N Schur; M D Laryea; H J Bremer; D Reinhardt; B Biggemann
Journal:  Eur J Pediatr       Date:  1990-04       Impact factor: 3.183

7.  Nutrigenetic response to omega-3 fatty acids in obese asthmatics (NOOA): rationale and methods.

Authors:  Jason E Lang; Edward B Mougey; Hooman Allayee; Kathryn V Blake; Richard Lockey; Yan Gong; Jobayer Hossain; Kelleigh Killen; John J Lima
Journal:  Contemp Clin Trials       Date:  2013-01-06       Impact factor: 2.226

8.  Fish Oil Supplementation in Overweight/Obese Patients with Uncontrolled Asthma. A Randomized Trial.

Authors:  Jason E Lang; Edward B Mougey; Md Jobayer Hossain; Floyd Livingston; P Babu Balagopal; Scott Langdon; John J Lima
Journal:  Ann Am Thorac Soc       Date:  2019-05

Review 9.  Dietary fish oil and airways obstruction.

Authors:  J Britton
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

10.  Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.

Authors:  S M Nasser; G S Bell; R J Hawksworth; K E Spruce; R MacMillan; A J Williams; T H Lee; J P Arm
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.